Modeling the impact of hepatitis C viral clearance on end-stage liver disease in an HIV co-infected cohort with targeted maximum likelihood estimation (Q4979239)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Modeling the impact of hepatitis C viral clearance on end-stage liver disease in an HIV co-infected cohort with targeted maximum likelihood estimation |
scientific article; zbMATH DE number 6305022
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Modeling the impact of hepatitis C viral clearance on end-stage liver disease in an HIV co-infected cohort with targeted maximum likelihood estimation |
scientific article; zbMATH DE number 6305022 |
Statements
Modeling the impact of hepatitis C viral clearance on end‐stage liver disease in an HIV co‐infected cohort with targeted maximum likelihood estimation (English)
0 references
17 June 2014
0 references
double-robust
0 references
inverse probability of treatment weighting
0 references
Kaplan-Meier
0 references
longitudinal data
0 references
marginal structural model
0 references
survival analysis
0 references
targeted maximum likelihood estimation
0 references
0 references
0 references
0.7042173743247986
0 references
0.6922772526741028
0 references
0.6871607303619385
0 references
0.6804751753807068
0 references
0.6749649047851562
0 references
